Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Dihydrocodeine hydrogen tartrate Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Dihydrocodeine hydrogentartrate Manufacturers in India Suppliers Dihydrocodeine hydrogentartrate Exporters Distributors Dihydrocodeine hydrogentartrate api active pharmaceuticals ingredients Dihydrocodeine hydrogentartrate manufacturers Side Effects bulk drugs raw material Dihydrocodeine hydrogentartrate companies Side Effects Importers Dihydrocodeine hydrogentartrate Dihydrocodeine hydrogentartrate Exporters Dihydrocodeine hydrogentartrate exporters FDA Dihydrocodeine hydrogentartrate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Dihydrocodeine hydrogentartrate manufacturing pharmaceutical drugs pharmaceutical intermediates Dihydrocodeine hydrogentartrate pharmaceutical chemicals pharmaceutical raw materials Dihydrocodeine hydrogentartrate active pharmaceutical ingredients Dihydrocodeine hydrogentartrate committee active pharmaceutical ingredients manufacturer Dihydrocodeine hydrogentartrate Active Pharmaceutical Ingredients manufacturer Dihydrocodeine hydrogentartrate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Dihydrocodeine hydrogentartrate, Dihydrocodeine hydrogentartrate manufacturer India, Dihydrocodeine hydrogentartrate product, Dihydrocodeine hydrogentartrate products, Api preparation, Certificate of Analysis API manufacturer product, Dihydrocodeine hydrogentartrate anti ulcer product, Certificate of Origin COA Dihydrocodeine hydrogentartrate COS Dihydrocodeine hydrogentartrate, pharmaceutical generic, pharmaceutical drug, medical, Dihydrocodeine hydrogentartrate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Dihydrocodeine hydrogentartrate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Dihydrocodeine hydrogentartrate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Dihydrocodeine hydrogentartrate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Dihydrocodeine hydrogentartrate ingredients, api, HIV Dihydrocodeine hydrogentartrate, tablets, capsules, syrup & protein Dihydrocodeine hydrogentartrate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Dihydrocodeine hydrogentartrate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Dihydrocodeine hydrogentartrate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

medicine

 

 

 

 















 

 

 

HOME >> API >> API List 4 >> Dihydrocodeine Hydrogen Tartrate >> Drug Description

Dihydrocodeine hydrogen tartrate

DRUG DESCRIPTION
Dihydrocodeine hydrogen tartrate
CAS Number:5965-13-9

Dihydrocodeine, also called DHC, Drocode, Paracodeine and Parzone and by the brand names of Synalgos DC, Panlor DC, Panlor SS, Contugesic, SS Bron, Drocode, Paracodin, Codidol, Didor Continus, Dicogesic, Codhydrine, Dekacodin, DH-Codeine, Didrate, Dihydrin, Hydrocodin, Nadeine, Novicodin, Rapacodin, Rikodeine,Fortuss, Remedeine, Dico, and DF-118 amongst others (e.g. PARAMOL), is a semi-synthetic opioid analgesic developed in Germany in the first decade of the 20th Century and put on the market in 1911. It is prescribed for postoperative pain, severe dyspnea, or as an antitussive. Dihydrocodeine tartrate is also present in co-dydramol. In some countries, controlled-release dihydrocodeine and/or the immediate release forumulations are used as an alternative to methadone in treatment of opioid dependency and addiction.

Commonly available as tablets, solutions, elixirs, and other oral forms, dihydrocodeine is also available in some countries as an injectable solution for deep subcutaneous and intra-muscular administration. Intravenous administration could be dangerous due to pulmonary oedema and the potential of anaphylaxis as it is with codeine. At one time in the past and possibly now, dihydrocodeine suppositories also existed.

Dihydrocodeine is used as an alternative to or incrementation on codeine for the above mentioned spectrum of situations. It is available as the following salts, in rough descending order of frequency of use: bitartrate, phosphate, hydrochloride, tartrate, hydroiodide, methyliodide, hydrobromide, and sulfate. The salt to free base conversion factors are 0,67 for the bitartrate, 0,73 for the phosphate, and 0,89 for the hydrochloride.

Dihydrocodeine was developed during the intense international search for more effective antitussives, especially to help reduce the airborne spread of tuberculosis, pertussis, pneumonia, and similar diseases, in the years from c.a. 1895 to 1915, and is similar in chemical structure to codeine. Depending on individual metabolism, dihydrocodeine is 100 to 150 percent as strong as codeine[citation needed]. Although dihydrocodeine does have extremely active metabolites, in the form of dihydromorphine and dihydromorphine-6-glucuronide (one hundred times more potent), these metabolites are produced in such small amount that they do not have clinically important effects.

Information Associated with Product:
DRUG DESCRIPTION >>
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Dihydrocodeine hydrogentartrate

Api Manufacturer,Export,Supplies,Manufacturing in India

Acenocoumarol

Aluminium-magnesium

Buprenorphine HCl

Dihydrocodeine hydrogentartrate

Ethylmorphine HCl

Glibornuride

Hydroxychloroquine sulphate

Noroxymorphone

Noscapine base

Oxycodone

Oxymorphone

Phenobarbital acid

Phenobarbital sodium

Thebaine

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.